Simulations Plus

$39.37 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Simulations Plus

Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company offers its products and services through two business segments, which include Simulations Plus, Inc. and Cognigen Corporation. Cognigen Corporation is the subsidiary of the Company. Its pharmaceutical/chemistry software is used by various companies, such as pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies for use in the conduct of industry-based research. Its clinical-pharmacology-based consulting services include pharmacokinetic and pharmacodynamics modeling, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions.

Stock Analysis

last close $39.37
1-mo return -1.8%
3-mo return -17.8%
avg daily vol. 136.99T
52-week high 90.92
52-week low 36.9
market cap. $802M
forward pe 69.4
annual div. 0.24
roe 11%
ltg forecast 15%
dividend yield 0.61%
annual rev. $46M
inst own. 73.6%
baraka

Subscribe now for daily local and international financial news

Subscribe